LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells

MLA

Weidong Li, et al. “LncRNA SNHG1 Contributes to Sorafenib Resistance by Activating the Akt Pathway and Is Positively Regulated by MiR-21 in Hepatocellular Carcinoma Cells.” Journal of Experimental & Clinical Cancer Research, vol. 38, no. 1, May 2019, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s13046-019-1177-0.

APA

Weidong Li, Xuesong Dong, Changjun He, Gang Tan, Ziyi Li, Bo Zhai, Jing Feng, Xian Jiang, Chang Liu, Hongchi Jiang, & Xueying Sun. (2019). LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells. Journal of Experimental & Clinical Cancer Research, 38(1), 1–13. https://doi.org/10.1186/s13046-019-1177-0

Chicago

Weidong Li, Xuesong Dong, Changjun He, Gang Tan, Ziyi Li, Bo Zhai, Jing Feng, et al. 2019. “LncRNA SNHG1 Contributes to Sorafenib Resistance by Activating the Akt Pathway and Is Positively Regulated by MiR-21 in Hepatocellular Carcinoma Cells.” Journal of Experimental & Clinical Cancer Research 38 (1): 1–13. doi:10.1186/s13046-019-1177-0.